Skip to main content

DEUTSCHE BANK AG\

Bank

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 948046 FRANKFURT AM MAIN, 2M

Position in VRDN

as of Mar 31, 2026 · filed May 6, 2026
Position Value
$20,192,100
+$5,262,032 QoQ
Shares Held
1,032,316
+115.2% QoQ
Ownership
1.00%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2022
16 quarters on record
Voting authority Sole 13% Shared 0% None 87%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

DEUTSCHE BANK AG\ holds $2,976,719,496 across 248 Biotechnology names. VRDN ranks #23 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in VRDN

Export CSV
16 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $20,192,100 1,032,316
2025-12-31 $14,930,068 479,758
2025-09-30 $20,230,536 937,467
2025-06-30 $5,409,392 386,938
2025-03-31 $5,348,970 396,808
2024-12-31 $7,723,093 402,874
2024-09-30 $8,634,693 379,547
2024-06-30 $630,268 48,445
2024-03-31 $818,994 46,773
2023-12-31 $931,987 42,791
2023-09-30 $337,831 22,023
2023-06-30 $2,204,237 92,654
2023-03-31 $6,464,659 254,114
2022-12-31 $499,082 17,086
2022-09-30 $227,270 11,081
2022-06-30 $147,725 12,768